and a horizon is nothing
save the limit of our sight.
-- Rossitier W. Raymond
PaperQuote [Daily Walpapers & Quotes]
Some who read and responded to my last entry may have been wondering if we are wavering about the the stem cell transplant (SCT). That is not the case. I was just reporting the candor of my physician in terms of the realistic chances for a cure, a probability around 20%. What this confirms: we have known for about 18 months that mantle cell lymphoma is a difficult disease to treat and cure. Not impossible, but not assured despite great advances in treatment of the disease.
Thursday, we had a family counseling session with Dr. Nakamura, Dee Dee, our two daughters, Suzanne and Andrea, and our case manager, Mona Sweinhart, RN, along with a social worker, Carlos, at City of Hope. During the session, our daughters had opportunity to ask their questions and to probe into details about the pending procedure. Both girls left the session satisfied that everything that can be done is being done on my behalf.
We also picked up a new schedule for the SCT that revealed my first five days of treatment, beginning Monday, Aug. 13, will be handled on an outpatient basis. I will not be admitted into the hospital transplant unit until the following Saturday, Aug. 18. The SCT is scheduled Aug. 22.
Meanwhile, what about the catharsis? Dee Dee and I are prepared for the journey, fully expecting that this procedure will give us our best chance of finding a cure. And while we are expecting a cure, we know that the journey comes with a considerable risk and a high potential of side-effects that the medical profession calls "morbidity." For a period of time during the next two months or so, I am likely to suffer ill effects from the treatment alone. The strong chemo and oblation of my immune system, followed by the infusion of the stem cells from the donor, will be the major steps in this process. Of course, we are not expecting complications, but these happen.
In our session Thursday with Dr. Nakamura, he shared his discussion with other members of the medical team. All of the physicians of that group agreed that the SCT is the correct decision. None of them would recommend a different course, although some suggested that in addition to the strong chemo, I should also receive heavy radiation treatment, but since that was a minority opinion, Dr. Nakamura has opted to prescribe chemo only prior to the SCT, due to the fact that my responses to chemo have been good, although not long-lasting.